Multiple-antibiotic-resistant strains of Serratia marcescens isolated from hospitalized patients were examined for their ability to transfer antibiotic resistance to Escherichia coli by conjugation. Two different patterns of linked transferable resistance were found among the transconjugants. The first comprised resistance to carbenicillin, streptomycin, and fosfomycin; the second, and more common, pattem included resistance to carbenicillin, streptomycin, kanamycin, gentamicin, tetracycline, chloramphenicol, sulfonamide, and fosfomycin. The two types of transconjugant strains carried a single plasmid of either 57 or 97 megadaltons in size. Both of these plasmids are present in parental S. marcescens strains resistant to fosfomycin. The 57-megadalton plasmid was transformed into E. coli.
Fosfomycin [(1,2-epoxypropyl)phosphonic acid] is a broad-spectrum antibiotic produced by Streptomyces fradiae. It inhibits bacterial growth in susceptible strains by interfering with cell wall biosynthesis (13) . As a therapeutic agent, it is widely used in the treatment of human infections in Spain (5) and in several other countries.
Development of resistance to fosfomycin in vitro has been reported in Escherichia coli and Salmonella typhimurium (8) . Also, a wide range of resistant strains belonging to different bacterial genera have been observed in hospitals (1, 5, 11) .
The most extensive studies on the mechanism of resistance have been caried out in E. coli. Two types of mutants have been described so far: one class of mutants has altered gipT and uph transport systems. The second class produces a target enzyme (PEP:UDPGlcNAc enolpyruvyl transferase, EC 2.5.1.7) with decreased affinity for fosfomycin (20) . The gipT and uph transport systems, aside from being used by their usual substrates, a-D-glycerophosphate and hexose-6-phosphate, are also used by fosfomycin for cellular entry (13) .
In the present work 31 strains of Serratia marcescens resistant to a number of antibiotics, including fosfomycin, were tested for the trans Table 1 together with their relevant phenotypic characteristics.
E. coli recipient strains used were W3110 Rifr, 185 Nalr, and C600 (leu thr thi lac).
Antibiotic susceptibility testing. Resistance to antibiotics was determined by the disk diffusion method. Altematively, single colonies were assayed by toothpick replica plating onto antibiotic-containing plates. The concentrations of antibiotics in plates were: carbenicillin, 500,ug/ml; streptomycin, 20 (Table 2 ). E. coli W3110 transconjugants which had received resistance markers were mated with E. coli 185 Nalr, selecting for carbenicillin (500 ,ug/ ml) and nalidixic acid (100 ,ug/ml) resistance. Transconjugants were obtained at a frequency similar to that found in the previous mating, except for the derivative from strain SM9, for which the frequency was lower. In all cases, however, the new transconjugants showed the same resistance pattems as the donors.
To test whether resistance to fosfomycin was being cotransferred with other resistance markers, 50 independent carbenicillin-resistant colonies from each mating were emulsified in fresh medium and plated on nonselective agar, as well as separately on agar containing carbenicillin and agar with fosfomycin. The numbers of single colonies obtained on the three different types of plates (about 100) were found to be the same.
We conclude from these experiments that re- sistance to fosfomycin in all three Serratia strains, SM5, SM7 and SM9, is transmissible and is linked to the other resistance markers. Plasmid DNA analysis. To determine the presence of plasmids in both parental S. marcescens strains and the E. coli transconjugants, three colonies of each were grown and lysed by the cleared lysate procedure. DNA was precipitated with isopropanol and analyzed by agarose gel electrophoresis. Parental S. marcescens strains showed the presence of several plasmids. Strain SM5 contained two plasmids of 97 and 49 megadaltons (Mdal) in size; strain SM9 carried three plasmids of 57, 50, and 5 Mdal. All E. coli transconjugants derived from SM5 and SM7 matings showed the presence of a single plasmid with electrophoretic mobility identical to that of the 97-Mdal molecular species present in parental Serratia strains SM5 and SM7. All of these plasmids carried resistance to carbenicillin, sulfonamide, kanamycin, gentamicin, tetracycline, and chloramphenicol in addition to fosfomycin. The plasmid derived from strain SM5 was designated pOU500, and that derived from SM7 was called pOU700.
The stability of pOU500 in E. coli 185 Nalr was tested in the following way. After prolonged incubation for 24 h in liquid antibiotic medium no. 3, 185(pOU500) cells were plated on nonselective medium. About 1,000 colonies were replicated onto plates containing separately the drugs corresponding to the different resistance markers. All but one clone grew well on all plates. The abnornal clone was found to have lost all the resistance markers of the plasmid, although it was still resistant to nalidixic acid. A cleared lysate was prepared from a culture of that clone and a sample was run on electrophoresis. It was found that the DNA band corresponding to plasmid pOU500 had disappeared, and no other band was present.
Transconjugants obtained from strain SM9 also carried a single plasmid (pOU900) of 57 Mdal in size. This is thought to be identical to the plasmid of the same size present in the parental Serratia strain (Fig. 1) . Plasmid pOU900 carried resistance to carbenicillin, streptomycin, and fosfomycin. Table 3 shows the minimal inhibitory concentrations of parental Serratia strains and E. coli transconjugants. It stresses the similarities between pOU500 and pOU700. When compared with the parental Serratia strains, E. coli W3110 (pOU900) seems to have lost four of the antibiotic resistance markers present in the SM9 strain while continuing to express a high level of resistance to fosfomycin and carbenicillin.
Transformation of plasmid DNA. Partially purified plasmid DNA (3 ,ug) isolated from E. coli 185 carrying pOU500, pOU700, and pOU900 was used to transform E. coli C600 selecting for carbenicillin resistance (500 ug/ml). No transfonnants were obtained when using pOU500 or pOU700 plasmid DNA. In contrast, plasmid pOU900 was transformed at a frequency of 7 x 102 transformed cells per jg of DNA. All transfornants carried the Cbr Smr For phenotype. Mini-cleared lysates prepared from four to five transformed colonies were subsequently analyzed by agarose gel electrophoresis. All lysates showed the presence of the 57-Mdal plasmid pOU900.
DISCUSSION
The appearance of an antibiotic resistance marker encoded by a plasmid after introduction of the particular drug into clinical practice has been described earlier (6, 14) . A number of different situations are now known in which the extensive use of a new antibiotic has rapidly been followed by the appearance of resistant strains which carry their resistance genes on a plasmid (7) . In the present case, it is interesting that although fosfomycin had been in clinical practice since 1971, no plasmid-linked strains had yet been found. Fosfomycin is an antibiotic which, in spite of good antibacterial activity, low toxicity and other favorable pharmacological properties (10, 18) , has not found worldwide use outside Spain. It is not surprising, therefore, that fosfomycin resistance plasmids should be found first in this country.
Some previous reports have also indicated the possible extrachromosomal nature of the fosfomycin resistance genes (12, 17 show a distinct antibiotic resistance pattem, and give rise to a different minimal inhibitory concentration for fosfomycin.
The 97-Mdal plasmids pOU500 and pOU700, although from different parental Serratia strains, could well be the same molecular species since both are indistinguishable on agarose gel electrophoresis and seem to specify identical minimal inhibitory concentrations of various antibiotics.
The reason that For plasmids are found in S. marcescens but not elsewhere is not apparent, but it could be related to the increased importance of this opportunistic pathogen in nosocomial infections (15) .
As to the mechanism of fosfomycin resistance specified by For plasmids, little is yet known.
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on August 27, 2017 by guest http://aac.asm.org/ Downloaded from of the type found in a class of chromosomal mutants (8, 9, 21, 19) is not likely, since E. coli strains carrying fosfomycin-resistant plasmids are able to grow and utilize a-D-glycerophosphate and glucose 6-phosphate as sole carbon and energy sources, unlike the resistant mutants in which genetic changes are chromosomal.
The possibility that resistant strains may produce an altered target enzyme has not been investigated. However, E. coli carrying For plasmids, unlike a chromosomal mutant described which produces an altered target enzyme with lower affinity for fosfomycin (19) , are not temperature sensitive with respect to growth.
